NEWS

• ALL
• 2022
• 2021
• 2019

• 2021.11.18
  Santen and ActualEyes sign a joint development agreement on Phase II clinical trial (Phase II a / PoC study) for a treatment candidate for Fuchs endothelial corneal dystrophy
• 2021.05.14
  ActualEyes and Arctic Vision announce a licensing agreement to develop and commercialize ActualEyes’ lead product candidate, AE-101.